# Gut-derived Neuropeptides in Cerebrospinal Fluid of Patients With Parkinson's Disease and Healthy Controls

> **NCT01792193** · — · COMPLETED · sponsor: **Dr. Marcus Unger** · enrollment: 40 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01792193
- **Lead sponsor:** Dr. Marcus Unger
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2016-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01792193

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01792193, "Gut-derived Neuropeptides in Cerebrospinal Fluid of Patients With Parkinson's Disease and Healthy Controls". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01792193. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*